Objective: To compare demographic characteristics of patients in the 3 FTLD subgroups.
2
Results: The frontotemporal dementia subgroup represented approximately half of all FTLD diagnoses.
3
The publication of consensus criteria for FTLD, however, prompted systematic studies.
4
FTLD is a more common form of dementia than previously recognized.
5
Recent findings have shown that this domain is hypomethylated in patients with FTLD-FUS.
Uso de frontotemporal lobar degeneration em inglês
1
Methods: Electronic databases were searched using terms related to frontotemporallobardegeneration and movement disorders.
2
Mutations in the gene encoding PGRN give rise to shortage of PGRN and cause familial frontotemporallobardegeneration.
3
Summary: This represents the first systematic review and meta-analysis of the occurrence of movement disorder phenomenology in genetic frontotemporallobardegeneration.
4
These findings further highlight that plasma PGRN levels may not accurately predict clinical features or response to future frontotemporallobardegeneration therapies.
5
Mutations in various RBPs cause several diseases of the central nervous system, including frontotemporallobardegeneration, amyotrophic lateral sclerosis and fragile X syndrome.
6
Objective: We conducted a systematic review and meta-analysis of the literature characterizing the spectrum and prevalence of movement disorders in genetic frontotemporallobardegeneration.
7
TDP-43 is a soluble, nuclear protein that undergoes cytoplasmic redistribution and aggregation in the majority of cases of amyotrophic lateral sclerosis and frontotemporallobardegeneration.
8
Pathological examinations, using a panel of tau and other antibodies, were performed on the brains from 55 consecutively acquired cases of frontotemporallobardegeneration (FTLD).
9
Transactivation-responsive DNA-binding protein 43 (TDP-43) is a component of pathological inclusions in amyotrophic lateral sclerosis and several forms of sporadic and familial frontotemporallobardegeneration.
10
The neuropathologic hallmark of frontotemporallobardegenerations is accumulation of abnormal proteins in the cytoplasm and nuclei of neurons and glial cells.
11
Frontotemporallobardegeneration (FTLD) is a devastating neurodegenerative disease that is the second most common form of dementia affecting individuals under age 65.
12
The aim of this review is to provide a summary of practical approaches for neuropathologic diagnostics of the rapidly evolving classifications of frontotemporallobardegenerations.
Translations for frontotemporal lobar degeneration